INNOVATE BIOPHARMACEUTICALS, INC. | Separation Agreements | Business Contracts

Separation Agreement, dated April 30, 2020, between Innovate Biopharmaceuticals, Inc. and Sandeep Laumas (Filed With SEC on May 4, 2020)

Separation Agreement, dated April 30, 2020, between Innovate Biopharmaceuticals, Inc. and Jay Madan (Filed With SEC on May 4, 2020)

Separation Agreement, dated February 19, 2019, by and between the Company and Christopher Prior (Filed With SEC on March 18, 2019)

Separation Agreement, dated November 16, 2018, by and between the Company and June Almenoff (Filed With SEC on March 18, 2019)

INNOVATE BIOPHARMACEUTICALS, INC. (58) | Separation Agreements (4)